Abstract: The present invention relates to a power fetching system for a no neutral switch and a control method thereof, and a no neutral switch, wherein the power fetching system is connected to an electrical device and a wireless controller, and the wireless controller controls a switch module for changing an operating state of the electrical device.

Abstract: The present invention relates to a dummy load circuit for a single live wire switch. This includes: a switch circuit—at least a first resistor and a switch are connected in the switch circuit, wherein the first resistor is connected to the switch, such that the first resistor is connected to the dummy load circuit through the switch; and a switch control circuit—the switch control circuit at least includes a switch control device, wherein the switch control device is connected to the switch to facilitate power-on/off control. The invention also relates to an electrical load with a dummy load circuit.

Abstract: Provided herein is an isolated decelluarized amniotic membrane (DCM) and methods for using same therapeutically in vivo and in vitro. In one aspect, the isolated DCM is further processed, freezing, freeze drying, lyophilization micronized into powder or treatment with pepsin to create a hydrogel.

Abstract: Provided are a zero-crossing detection device and a method thereof, a no-neutral switch, a storage medium and a processor. The no-neutral switch may include a switch element, the switch element has a first end connected to a power supply and a second end connected to a load, and the zero-crossing detection device may include: a sampling module configured to sample a first signal of the first end of the switch element and a second signal of the second end of the switch element; a comparison module configured to compare a deviation of the first signal and the second signal with a preset threshold; and a computing module configured to compute a zero-crossing point of the power supply according to a comparison result of the comparison module and the preset threshold.

Abstract: The present invention relates to a smart equipment, a method used by a smart equipment, and a smart lamp. The smart equipment comprises a WiFi module and a Bluetooth Low Energy (BLE) module. The BLE module comprises a microcontroller unit (MCU). The WiFi module wirelessly downloads an OTA file. The microcontroller unit divides the OTA file into at least one packages. The Bluetooth Low Energy (BLE) module OTA upgrades a plurality of devices in a mesh network simultaneously by broadcasting the at least one packages.

Abstract: The present disclosure provides pro-angiogenic proteoglycan mimetics that can provide a provisional, pro-angiogenic scaffold to support tissue regeneration while limiting systemic exposure to VEGF activity. These mimetics can protect a collagen matrix from rapid degradation, and in conjunction with EPCs promote angiogenesis in order to accelerate ischemic wound healing. For example, the provided compounds can be delivered from the end of a catheter following balloon angioplasty to coat the collagen exposed areas, prevent platelet binding and thrombosis, support capture of EPCs from blood to facilitate reendothelialization, and reduce late-lumen loss (neointimal hyperplasia).

Abstract: An enhanced smart lighting system (ESLS) for use in buildings without neutral wire connections for wall switches. The ESLS entails both a no-neutral wire smart lighting switch (NNWSLS) and a physically separate load adapter. The NNWSLS includes a sensing, control, or communication system (SSCCS) such as integrated WiFi. The load adapter mitigates electrical fluctuations which may be induced in a power load (for example a lightbulb) by the smart lighting switch, particularly when the smart lighting switch is nominally powered off but still has some current flow. The load adapter is an intermediary between the power load and a conventional load receptacle. The load adapter has an integrated dummy load configured in parallel with the power load. The dummy load provides an electrical pathway for low levels of electricity which run through the light socket even when the NNWSLS is set to an “off” configuration.

Abstract: The application relates to a device control method and apparatus, a storage medium, a processor, a terminal, and a computer program product.

Abstract: The present invention relates to a dummy load circuit for a single live wire switch. This includes: a switch circuit—at least a first resistor and a switch are connected in the switch circuit, wherein the first resistor is connected to the switch, such that the first resistor is connected to the dummy load circuit through the switch; and a switch control circuit—the switch control circuit at least includes a switch control device, wherein the switch control device is connected to the switch to facilitate power-on/off control. The invention also relates to an electrical load with a dummy load circuit.

Abstract: The present invention relates to a power fetching system for a no neutral switch and a control method thereof, and a no neutral switch, wherein the power fetching system is connected to an electrical device and a wireless controller, and the wireless controller controls a switch module for changing an operating state of the electrical device.

Abstract: The present disclosure relates to PWM dimming circuit with low stand-by power. A lighting apparatus driver is provided, comprising: a power supplier to supply power to a lighting load; and a discrete PWM dimming circuit, the PWM dimming circuit is to receive PWM signal, and to control the switching of the power supplier based on the PWM signal, wherein the power supplier is capable of being turned off by the PWM dimming circuit.

Abstract: A method and apparatus for device finding after network configuration are disclosed. The method for device finding includes: sending a message to a smart device in an Access Point (AP) mode, the message comprising information for connecting to a first router or AP; changing connection from the smart device to a network; performing a local scanning when connecting to the first router or AP; and performing a cloud scanning when the local scanning fails.

Abstract: A presence sensing method for a light comprises detecting a presence of a user by a sensing module having a first sensitivity while the light is off; turning on the light when identifying the presence of the user and keeping the light on for a delay time period which has a preset length; increasing a sensitivity of the sensing module to a second sensitivity after turning on the light; detecting actions of the user by the sensing module having the second sensitivity while the light is on; determining a length of a next delay time period based on the actions of the user during the previous delay time period immediately prior to the next delay time period; and keeping the light on for the next delay time period.

Abstract: A presence sensing method for a light comprises detecting a presence of a user by a sensing module having a first sensitivity while the light is off; turning on the light when identifying the presence of the user and keeping the light on for a delay time period which has a preset length; increasing a sensitivity of the sensing module to a second sensitivity after turning on the light; detecting actions of the user by the sensing module having the second sensitivity while the light is on; determining a length of a next delay time period based on the actions of the user during the previous delay time period immediately prior to the next delay time period; and keeping the light on for the next delay time period.

Abstract: The present invention provides scaffolds that include a polymer and a cyclic peptide ligand. The peptide ligand increases the attachment of endothelial cells and/or progenitor cells to the scaffold. The present invention also provides engineered tissues that include the provided scaffolds. The present invention also provides coatings that include a coating polymer and a cyclic peptide ligand. The present invention also provides methods of improving endothelialization and vascularization of endothelial cells and/or progenitor cells for tissue regeneration in a subject and of repairing bone defects in a subject, by implanting a provided scaffold.

Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Abstract: Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.

Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.